TY - JOUR A1 - Wegner, Martin A1 - Diehl, Valentina A1 - Bittl, Verena A1 - Bruyn, Rahel de A1 - Wiechmann, Svenja A1 - Matthess, Yves A1 - Hebel, Marie A1 - Hayes, Michael G. B. A1 - Schaubeck, Simone A1 - Benner, Christopher A1 - Heinz, Sven A1 - Bremm, Anja A1 - Đikić, Ivan A1 - Ernst, Andreas A1 - Kaulich, Manuel T1 - Circular synthesized CRISPR/Cas gRNAs for functional interrogations in the coding and noncoding genome T2 - eLife N2 - Current technologies used to generate CRISPR/Cas gene perturbation reagents are labor intense and require multiple ligation and cloning steps. Furthermore, increasing gRNA sequence diversity negatively affects gRNA distribution, leading to libraries of heterogeneous quality. Here, we present a rapid and cloning-free mutagenesis technology that can efficiently generate covalently-closed-circular-synthesized (3Cs) CRISPR/Cas gRNA reagents and that uncouples sequence diversity from sequence distribution. We demonstrate the fidelity and performance of 3Cs reagents by tailored targeting of all human deubiquitinating enzymes (DUBs) and identify their essentiality for cell fitness. To explore high-content screening, we aimed to generate the largest up-to-date gRNA library that can be used to interrogate the coding and noncoding human genome and simultaneously to identify genes, predicted promoter flanking regions, transcription factors and CTCF binding sites that are linked to doxorubicin resistance. Our 3Cs technology enables fast and robust generation of bias-free gene perturbation libraries with yet unmatched diversities and should be considered an alternative to established technologies. KW - Tools and ressources KW - cell biology KW - genetics and genomics KW - Crispr/Cas KW - gRNA library KW - 3Cs technology KW - genome-wide KW - DUBs KW - Doxorubicin KW - human Y1 - 2019 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/48808 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-488081 SN - 2050-084X N1 - Copyright Wegner et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited. VL - 8 IS - e42549 SP - 1 EP - 31 PB - eLife Sciences Publications CY - Cambridge ER -